Page 146 - MEMORIA ANUAL 2020
P. 146

   GRUPO ESPAÑOL DE LEUCEMIA MIELOIDE CRÓNICA (GELMC)
MEMORIA ANUAL 2020 SOCIEDAD ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA
FUNDACIÓN ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA
Publicaciones en revistas científicas
Internacionales
• Effective quantification of 11 tyrosine kinase inhibitors and caffeine in human plasma by validated LC-MS/MS method with potent phospholipids clean-up procedure. Application to therapeutic drug monitoring.
Talanta. 2020 Feb 1;208:120450. doi: 10.1016/j.talanta.2019.120450. Epub 2019 Oct 11. PMID: 31816725.
Koller D, Vaitsekhovich V, Mba C, Steegmann JL, Zubiaur P, Abad-Santos F, Wojnicz A.
• Dasatinib discontinuation in patients with chronic-phase chronic myeloid leukemia and sta- ble deep molecular response: the DASFREE study.
Leuk Lymphoma. 2020 Mar;61(3):650-659. doi: 10.1080/10428194.2019.1675879. Epub 2019 Oct 24. PMID: 31647335.
• European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia. 2020 Apr;34(4):966-984. doi: 10.1038/s41375-020-0776-2. Epub 2020 Mar 3. PMID: 32127639.
Hochhaus A, Baccarani M, Silver RT, Schiffer C, Apperley JF, Cervantes F, Clark RE, Cortes JE, Deininger MW, Guilhot F, Hjorth-Hansen H, Hughes TP, Janssen JJWM, Kantarjian HM, Kim DW, Larson RA, Lipton JH, Mahon FX, Mayer J, Nicolini F, Niederwieser D, Pane F, Radich JP, Rea D, Richter J, Rosti G, Rousselot P, Saglio G, Saußele S, Soverini S, Steegmann JL, Turkina A, Zaritskey A, Hehlmann R.
• Early prediction of subsequent molecular response to nilotinib in patients with chronic my- eloid leukemia: comparison of the quantification of BCR-ABL1 ratios using ABL1 or GUSB control genes.
J Mol Diagn. 2020 Oct;22(10):1217-1224. doi: 10.1016/j.jmoldx.2020.06.016. Epub 2020 Jul 17. PMID: 32688056. Publicación compartida con el GBMH.
Stuckey R, Casado LF, Colomer D, Gómez-Casares MT, Casas L, García-Gutiérrez V, Sastre JL, Ramírez-Payer Á, Vall-Llovera F, Goñi MÁ, Xicoy B, Godoy AC, Núñez J, Mora I, Vallansot R, López-Lorenzo JL, Palomera L, Conesa V, Noya MS, Sánchez-Guijo F, Peña A, Bautista G, Steeg- mann JL.
146
 
















































































   144   145   146   147   148